TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress

American Journal of Physiology - Cell Physiology

Volumn 298, Issue 6, 2010, Pages

  Hicks, Kali ^a   O'Neil, Roger G ^a   Dubinsky, William S ^a,b   Brown, Rachel C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

Author keywords

Blood brain barrier; Calcium; Cation channels; Endothelial cell; Stroke; Transient receptor potential C channels

Indexed keywords

1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ACTIN; ACTIN BINDING PROTEIN; CALCIUM; MOESIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN ZO1; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACTIN MYOSIN INTERACTION; ACTIN POLYMERIZATION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME INHIBITION; MEMBRANE CHANNEL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS;

ACTINS; ANIMALS; AZEPINES; BLOOD-BRAIN BARRIER; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL ADHESION MOLECULES; CELL HYPOXIA; CELL LINE; CELL SHAPE; ENDOTHELIAL CELLS; ENZYME INHIBITORS; IMIDAZOLES; MICE; MICROFILAMENT PROTEINS; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; MYOSINS; NAPHTHALENES; PERMEABILITY; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEOMICS; STRESS, PHYSIOLOGICAL; TIGHT JUNCTIONS; TIME FACTORS; TRPC CATION CHANNELS;

EID: 77952615173     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00458.2009     Document Type: Article

References (69)

1. Agam K, von Campenhausen M, Levy S, Ben-Ami H, Cook B, Kirschfeld K, Minke B. Metabolic stress reversibly activates the Drosophila light-sensitive channels TRP and TRPL in vivo. J Neurosci 20: 5748-5755, 2000. (Pubitemid 30636903)
2. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16: 1-13, 2004.
3. Bright R, Steinberg GK, Mochly-Rosen D. DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res 1144: 146-155, 2007. (Pubitemid 46440848)
4. Brown R, Wu L, Hicks K, O'Neil RG. Regulation of blood-brain barrier permeability by transient receptor potential type C and type V calcium-permeable channels. Microcirculation 15: 359-371, 2008. (Pubitemid 351903350)
5. Brown RC, Davis TP. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun 327: 1114-1123, 2005. (Pubitemid 40142636)
6. Brown RC, Mark KS, Egleton RD, Davis TP. Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol 286: C1045-C1052, 2004.
7. Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs A, Davis TP. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J Cell Sci 116: 693-700, 2003. (Pubitemid 36231308)
8. Brown RC, Morris AP, O'Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130: 17-30, 2007.
9. Cai H, Liu D, Garcia JG. CaM kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc Res 77: 30-34, 2008. (Pubitemid 351195142)
10. Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, Leon OS, Fiebich BL. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 100: 1108-1120, 2007. (Pubitemid 46213933)
11. Chiang E, Lim M, Patton W, Shepro D. NFkappaB translocation in human microvessel endothelial cells using a four-compartment subcellular protein redistribution assay. J Biochem Biophys Methods 46: 53-68, 2000.
12. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J 16: 583-585, 2002.
13. Du Y, Danjo K, Robinson PA, Crabtree JE. In-cell Western analysis of Helicobacter pylori-induced phosphorylation of extracellular-signal related kinase via the transactivation of the epidermal growth factor receptor. Microbes Infect 9: 838-846, 2007. (Pubitemid 46891853)
14. 2+ entry in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 285: L1233-L1245, 2003.
15. Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol 198: 359-369, 2004. (Pubitemid 38235031)
16. Fleegal M, Hom S, Borg L, Davis TP. Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol 289: H2012-H2019, 2005. (Pubitemid 41507352)
17. Furman C, Sieminski A, Kwiatkowski A, Rubinson D, Vasile E, Bronson R, Fassler R, Gertler F. Ena/VASP is required for endothelial barrier function in vivo. J Cell Biol 179: 761-775, 2007. (Pubitemid 350146260)
18. Garcia J, Davis H, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163: 510-522, 1995.
19. 2+/calmodulin binding and activation of myosin light chain kinase in cells. FEBS Lett 557: 121-124, 2004.
20. Gu S, Liu Z, Pan S, Jiang Z, Lu H, Amit O, Bradbury EM, Hu CA, Chen X. Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol Cell Proteomics 3: 998-1008, 2004. (Pubitemid 40361234)
21. Gygi SP, Aebersold R. Mass spectrometry and proteomics. Curr Opin Chem Biol 4: 489-494, 2000.
22. Han F, Shirasaki Y, Fukunaga K. Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain. J Neurochem 99: 97-106, 2006. (Pubitemid 44395133)
23. Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, Persidsky Y. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol Clin Exp Res 29: 999-1009, 2005. (Pubitemid 40934204)
24. Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem 101: 566-576, 2007. (Pubitemid 46525283)
25. Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol Heart Circ Physiol 273: H2442-H2451, 1997. (Pubitemid 27508324)
26. Ikeda K, Nagashima T, Wu S, Yamaguchi M, Tamaki N. The role of calcium ion in anoxia/reoxygenation damage of cultured brain capillary endothelial cells. Acta Neurochir Suppl 70: 4-7, 1997. (Pubitemid 127502035)
27. Jin HG, Yamashita H, Nagano Y, Fukuba H, Hiji M, Ohtsuki T, Takahashi T, Kohriyama T, Kaibuchi K, Matsumoto M. Hypoxia-induced upregulation of endothelial small G protein RhoA and Rhokinase/ ROCK2 inhibits eNOS expression. Neurosci Lett 408: 62-67, 2006. (Pubitemid 44466202)
28. Kahle KT, Simard JM, Staley KJ, Nahed BV, Jones PS, Sun D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) 24: 257-265, 2009.
29. Kayyali U, Pennella C, Trujillo C, Villa O, Gaestel M, Hassoun P. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 277: 42596-42602, 2002. (Pubitemid 35285628)
30. Kiedrowski L. NCX and NCKX operation in ischemic neurons. Ann NY Acad Sci 1099: 383-395, 2007. (Pubitemid 47092598)
31. Koss M, Pfeiffer G, Wang Y, Thomas S, Yerukhimovich M, Gaarde W, Doerschuk C, Wang Q. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 176: 1218-1227, 2006. (Pubitemid 43099726)
32. Krause M, Dent E, Bear J, Loureiro J, Gertler F. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19: 541-564, 2003. (Pubitemid 37487360)
33. Krizbai IA, Bauer H, Bresgen N, Eckl PM, Farkas A, Szatmari E, Traweger A, Wejksza K, Bauer HC. Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell Mol Neurobiol 25: 129-139, 2005. (Pubitemid 40558586)
34. Kuhlmann CR, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS, Luhmann HJ. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 102: 501-507, 2007. (Pubitemid 47000593)
35. Kuhlmann CR, Zehendner CM, Gerigk M, Closhen D, Bender B, Friedl P, Luhmann HJ. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neurosci Lett 449: 168-172, 2009.
36. Lai DM, Li H, Lee CC, Tzeng YS, Hsieh YH, Hsu WM, Hsieh FJ, Cheng JT, Tu YK. Angiopoietin-like protein 1 decreases blood brain barrier damage and edema following focal cerebral ischemia in mice. Neurochem Int 52: 470-477, 2008.
37. 2+ switch. Am J Physiol Cell Physiol 282: C1235-C1245, 2002.
38. 2+ pumps (PMCAs) in pathologies of mammalian cells. Front Biosci 7: d53-d84, 2002.
39. Lennmyr F, Ericsson A, Gerwins P, Ahlstrom H, Terent A. Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia. Acta Neurol Scand 108: 339-345, 2003. (Pubitemid 37357638)
40. 2+ channels in pulmonary artery smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 95: 496-505, 2004.
41. Louvet-Vallee S. ERM proteins: from cellular architecture to cell signaling. Biol Cell 92: 305-316, 2000.
42. Mark KS, Burroughs A, Brown RC, Huber JD, Davis TP. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am J Physiol Heart Circ Physiol 286: H174-H180, 2004. (Pubitemid 38049477)
43. Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282: H1485-H1494, 2002.
44. Matsui T, Maeda M, Doi Y, Yonemura S, Amano MK, K , Tsukita S, Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140: 647-657, 1998. (Pubitemid 28134067)
45. McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR, Brooks TA, Davis T. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem 106: 2395-2409, 2008.
46. McCaffrey G, Willis C, Staatz W, Nametz N, Quigley CH, SA, Lochhead JJ, Davis TP. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem 110: 58-71, 2009.
47. 2+ entry. Role in signaling increased endothelial permeability. J Biol Chem 278: 33492-33500, 2003.
48. Mery L, Strauss B, Dufour J, Krause K, Hoth M. The PDZ-interacting domain of TRPC4 controls its localization and surface expression in HEK293 cells. J Cell Sci 115: 3497-3508, 2002. (Pubitemid 34994039)
49. Montesano R, Pepper M, Mohle-Steinlein U, Risau W, Wagner E, Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62: 435-445, 1990. (Pubitemid 20263214)
50. Nairn A, Picciotto M. Calcium/calmodulin-dependent kinases. Semin Cancer Biol 5: 295-303, 1994.
51. Nakamuta S, Endo H, Higashi Y, Kousaka A, Yamada H, Yano M, Kido H. Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells. J Neurovirol 14: 186-195, 2008. (Pubitemid 351895540)
52. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M. Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake transport studies. Brain Res 990: 95-112, 2003. (Pubitemid 37247600)
53. Park JH, Okayama N, Gute D, Krsmanovic A, Battarbee H, Alexander JS. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am J Physiol Cell Physiol 277: C1066-C1074, 1999. (Pubitemid 30045963)
54. Pietromonaco SS, PC, Altman A, Elias L. Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence. J Biol Chem 273: 7594-7603, 1998. (Pubitemid 28153699)
55. Pilot F, Philippe JM, Lemmers C, Lecuit T. Spatial control of actin organization at adherens junctions by a synaptotagmin-like protein Btsz. Nature 442: 580-584, 2006. (Pubitemid 44167918)
56. Pun P, Lu JM, S. Involvement of ROS in BBB dysfunction. Free Radic Res 43: 348-364, 2009.
57. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32: 200-219, 2008.
58. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21: 3666-3676, 2007.
59. Shimojima N, Eckman C, McKinney M, Sevlever D, Yamamoto S, Lin W, Dickson D, Nguyen J. Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure. J Invest Surg 21: 101-108, 2008. (Pubitemid 351935706)
60. 2+ entry in TRPC4-/- mice interferes with increase in lung microvascular permeability. Circ Res 91: 70-76, 2002.
61. Ueno M. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. Curr Med Chem 14: 1199-1206, 2007. (Pubitemid 46739321)
62. Vetter SW, Leclerc E. Novel aspects of calmodulin target recognition and activation. Eur J Biochem 270: 404-414, 2003. (Pubitemid 36177307)
63. Vogel C, Bauer A, Wiesnet M, Preissner KT, Schaper W, Marti HH, Fischer S. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol 212: 236-243, 2007. (Pubitemid 46867606)
64. Wang X, Pluznick JL, Settles DC, Sansom SC. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells. Am J Physiol Renal Physiol 293: F1768-F1776, 2007. (Pubitemid 350179600)
65. Wojciak-Stothard B, Tsang LY, Haworth SG. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 288: L749-L760, 2005. (Pubitemid 40404144)
66. Woodward A, Crouch D. Cellular distribution of the ERM proteins in MDCK epithelial cells: regulation by growth and cytoskeletal integrity. Cell Biol Int 25: 205-212, 2001.
67. Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 72: 440-449, 2007.
68. Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging 26: 207-227, 2005. (Pubitemid 39610462)
69. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-838, 2000.